We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
-5.67%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$15.3B
AUM Growth
-$1.2B
Cap. Flow
+$102M
Cap. Flow %
0.67%
Top 10 Hldgs %
32.45%
Holding
1,302
New
280
Increased
463
Reduced
337
Closed
213

Top Buys

Rank Stock Value
1
CP icon
Canadian Pacific Kansas City
CP
+$77.5M
2
TSM icon
TSMC
TSM
+$73.8M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$60.9M
4
CNI icon
Canadian National Railway
CNI
+$56.1M
5
RBA icon
RB Global
RBA
+$41.5M

Top Sells

Rank Stock Value
1
BNS icon
Scotiabank
BNS
+$79.6M
2
SU icon
Suncor Energy
SU
+$62.4M
3
BCE icon
BCE
BCE
+$51.4M
4
BMO icon
Bank of Montreal
BMO
+$46.8M
5
AZN icon
AstraZeneca
AZN
+$38.4M

Sector Composition

Rank Sector Weight
1 Financials 26.03%
2 Industrials 15.28%
3 Energy 13.03%
4 Technology 11.16%
5 Materials 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRD.A icon
1001
Crawford & Co Class A
CRD.A
$626M
$185K ﹤0.01%
32,305
-594
-2% -$3.97K
RLX icon
1002
RLX Technology
RLX
$2.44B
$181K ﹤0.01%
171,958
+71,380
+71% +$109K
AVEO
1003
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$177K ﹤0.01%
+21,563
New +$166K
QUAD icon
1004
Quad
QUAD
$502M
$176K ﹤0.01%
68,904
-1,635
-2% -$5.35K
HAPN
1005
Happen Inc
HAPN
$2.28B
$175K ﹤0.01%
15,830
-67,248
-81% -$905K
ABUS icon
1006
Arbutus Biopharma
ABUS
$898M
$173K ﹤0.01%
+90,497
New +$213K
PENG
1007
Penguin Solutions Inc
PENG
$3.2B
$166K ﹤0.01%
+10,477
New +$191K
ORIC icon
1008
Oric Pharmaceuticals
ORIC
$1.44B
$163K ﹤0.01%
50,809
+29,746
+141% +$119K
CMCM
1009
Cheetah Mobile
CMCM
$94.7M
$162K ﹤0.01%
80,762
-16,923
-17% -$57.2K
FCF icon
1010
First Commonwealth Financial
FCF
$2.18B
$162K ﹤0.01%
+12,579
New +$176K
AKBA icon
1011
Akebia Therapeutics
AKBA
$243M
$161K ﹤0.01%
510,102
+283,332
+125% +$111K
VHC icon
1012
VirnetX Holding Corp
VHC
$67.6M
$159K ﹤0.01%
6,801
+449
+7% +$14.5K
HTGC icon
1013
Hercules Capital
HTGC
$3.15B
$158K ﹤0.01%
+13,658
New +$195K
OSPN icon
1014
OneSpan
OSPN
$603M
$154K ﹤0.01%
17,930
-17,325
-49% -$187K
PVLA
1015
Palvella Therapeutics
PVLA
$2.25B
$154K ﹤0.01%
1,671
+565
+51% +$72.8K
ASYS icon
1016
Amtech Systems
ASYS
$284M
$153K ﹤0.01%
18,014
-646
-3% -$5.95K
BCEL
1017
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$153K ﹤0.01%
97,264
+42,963
+79% +$88.3K
AAOI icon
1018
Applied Optoelectronics
AAOI
$11.4B
$152K ﹤0.01%
+55,918
New +$126K
DTIL icon
1019
Precision BioSciences
DTIL
$200M
$152K ﹤0.01%
3,893
+488
+14% +$23.2K
ZYME icon
1020
Zymeworks
ZYME
$1.83B
$151K ﹤0.01%
24,583
+8,296
+51% +$50K
ATRA icon
1021
Atara Biotherapeutics
ATRA
$74.9M
$149K ﹤0.01%
1,572
-2,624
-63% -$295K
SID icon
1022
Companhia Siderúrgica Nacional
SID
$1.17B
$149K ﹤0.01%
+62,756
New +$173K
HCM icon
1023
HUTCHMED
HCM
$2.1B
$148K ﹤0.01%
+16,664
New +$210K
IOVA icon
1024
Iovance Biotherapeutics
IOVA
$2.97B
$146K ﹤0.01%
+15,250
New +$176K
BDTX icon
1025
Black Diamond Therapeutics
BDTX
$117M
$140K ﹤0.01%
82,881
+70,551
+572% +$218K
39 40
41
42 43

Similar funds

State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s Q3 2022 Portfolio in Review

As of Q3 2022, Connor, Clark & Lunn Investment Management (CC&L) held 1,302 positions worth $15.3B, down 7.3% from $16.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L)'s Q3 2022 filing shows 280 new, 463 increased, 337 reduced and 213 closed positions. Its largest new stake was VICI Properties: 544,471 shares worth $16.3M. The largest sale was Scotiabank, an estimated $79.6M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 28% a quarter earlier, followed by Industrials and Energy.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q3 2022 buy was VICI Properties: 544,471 shares worth $16.3M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Canadian Pacific Kansas City in Q3 2022, an estimated $77.5M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q3 2022 reduction was Scotiabank, cutting an estimated $79.6M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited United Airlines in Q3 2022, selling an estimated $30.6M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 32% of its $15.3B portfolio in Q3 2022.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 280 new positions and closed 213 in Q3 2022.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 7.3% quarter-over-quarter to $15.3B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2022, filed 10 Nov 2022.